Marina Tembulatovna Nalchikova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Marina Tembulatovna Nalchikova has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Dzhannet Anuarovna Elmurzaeva
Kabardino-Balkarian State University
1 shared publication - Dzhanneta Magometovna Urusbieva
Berbekov Kabardino-Balkarian State University
1 shared publication - Inara Aslanovna Khakuasheva
Berbekov Kabardino-Balkarian State University
1 shared publication - Sofiat Khasenovna Sizhazheva
Department of Public Health, Health Care and Preventive Medicine Kabardino-Balkarian State University named after H.M. Berbekov Nalchik, Russia
1 shared publication - Svetlana Sergeevna Solyanik
Department of Pharmacy (course of Pharmacology, clinical pharmacology) Kabardino-Balkarian state University named after H.M. Berbekov Nalchik, Russia
1 shared publication - Tamara Muratovna Khokonova
Department of Microbiology, Virology, and Immunology, Kabardino-Balkar Berbekov’s State University, 176 Chernishevskogo St., 360000 Nal’chik, Russia
1 shared publication
Latest Publications
- Open Access
- 8 May 2021
- Published by Universidad del Zulia in Revista de la Universidad del Zulia
- Vol. 12 (33) , 274-287
Analysis of hemodynamic parameters and quality of life in patients with chronic kidney disease and arterial hypertension
Purpose. The work is devoted to study the effects of antihypertensive, lipid-lowering and metabolic therapy in office and the average hemodynamic parameters, the parameters of central pressure in the aorta, vascular wall stiffness and quality of life in patients with CKD stage 3 in combination with arterial hypertension of 1-2 degrees, and without it. Materials and methods. Were examined patients with arterial hypertension of 1-2 degrees and CKD stage 3. Measured hemodynamic parameters with the help of a daily BP monitor “BPLab”. The quality of life of patients was assessed by the questionnaire MOS SF36. Results. The greatest changes in the indicators of central hemodynamics and vascular stiffness were noted in the group of patients with comorbidity. Conclusion. The combination of antihypertensive therapy (losartan and diltiazem) with meldonium and rosuvastatin significantly decreases indices of central and peripheral hemodynamics and vascular stiffness. Add meldonium part of therapy significantly improves the quality of life of patients.
- 8 May 2021
- Published by Universidad del Zulia in Revista de la Universidad del Zulia
- Vol. 12 (33) , 274-287
Open AccessAnalysis of hemodynamic parameters and quality of life in patients with chronic kidney disease and arterial hypertension
Purpose. The work is devoted to study the effects of antihypertensive, lipid-lowering and metabolic therapy in office and the average hemodynamic parameters, the parameters of central pressure in the aorta, vascular wall stiffness and quality of life in patients with CKD stage 3 in combination with arterial hypertension of 1-2 degrees, and without it. Materials and methods. Were examined patients with arterial hypertension of 1-2 degrees and CKD stage 3. Measured hemodynamic parameters with the help of a daily BP monitor “BPLab”. The quality of life of patients was assessed by the questionnaire MOS SF36. Results. The greatest changes in the indicators of central hemodynamics and vascular stiffness were noted in the group of patients with comorbidity. Conclusion. The combination of antihypertensive therapy (losartan and diltiazem) with meldonium and rosuvastatin significantly decreases indices of central and peripheral hemodynamics and vascular stiffness. Add meldonium part of therapy significantly improves the quality of life of patients.